Viewing Study NCT05098405

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:19 AM
Ignite Modification Date: 2026-04-14 @ 3:54 PM
Study NCT ID: NCT05098405
Status: TERMINATED
Last Update Posted: 2025-01-30
First Post: 2021-09-30
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: First-in-human Safety and Tolerability of MP0317 in Patients With Relapsed/Refractory Advanced Solid Tumors
Sponsor: Molecular Partners AG
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Malignant Solid Tumor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Designed ankyrin repeat protein View
None DARPin® View
None fibroblast activation protein View
None CD40 antigen View
None advanced malignant solid neoplasm View
None relapsed malignant solid neoplasm View
None refractory malignant solid neoplasm View